Close Menu

NEW YORK (360Dx) – Bio-Rad Laboratories said Thursday that the US Food and Drug Administration has cleared its BioPlex 2200 ToRC IgM Assay, an automated and multiplexed panel for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV).

Toxoplasma gondii, rubella, and CMV are pathogens commonly associated with congenital diseases and therefore are tested during the first trimester of pregnancy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.